Results 161 to 170 of about 9,912 (208)

Dipeptidyl Peptidase-4 Inhibitors Associated with Lower Psoriatic Disease Risk in Type 2 Diabetes: A 13-Year Nationwide Cohort Study with Mechanistic Validation. [PDF]

Acta Derm Venereol
Hung CT, Chung CH, Weng TH, Tsai CT, Chien WC, Chang YL.   +5 more
europepmc   +1 more source

The Caenorhabditis elegans DPF-3 and human DPP4 have tripeptidyl peptidase activity. [PDF]

FEBS Lett
Trivedi A, Gudipati RK.
europepmc   +1 more source

Efficacy and Safety of Vildagliptin Sustained-Release and Metformin Sustained-Release Fixed-Dose Combination in Indian Patients With Type 2 Diabetes Mellitus: A Real-World Perspective. [PDF]

Cureus
Sarda A, Sosale B, Jagan Mohan B, Tanna S, Gupta V, Gupta S, Langade D, Kotwal R, Kolapkar V, Patel K.   +9 more
europepmc   +1 more source

Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial. [PDF]

Front Endocrinol (Lausanne)
Yang X, Zhang X, Sun C, Zhao C, Kong X, Zhao M, Ji L, Li Y.   +7 more
europepmc   +1 more source

Reduced Weight Gain with Pioglitazone vs Vildagliptin in <i>CREBRF</i> rs373863828 A-allele Carriers: Insights from the WORTH Trial. [PDF]

Diabetes Metab Syndr Obes
Toomata ZLL, Jiang Y, Yeu RQ, Brandon R, Tweedie-Cullen RY, Nehren N, Doherty G, Watson H, Macaskill-Smith KA, Leask M, Merriman TR, Paul R, Merry TL, Shepherd PR, Murphy R.   +14 more
europepmc   +1 more source

Bullous pemphigoid associated with vildagliptin in an elderly adult with diabetes mellitus. First case in Peru. [PDF]

Rev Peru Med Exp Salud Publica
Concepción-Zavaleta M, Armas CD, Quiroz-Aldave JE, Ángeles-Zavaleta J, Durand-Vásquez MDC, Paz-Ibarra J, Quispe-Meza JY, Concepción-Urteaga L.   +7 more
europepmc   +1 more source

Henoch-Schönlein purpura induced by sitagliptin: A case report. [PDF]

SAGE Open Med Case Rep
Moschella A, Kirshen C.
europepmc   +1 more source

Eco-Friendly electrochemical sensor for vildagliptin detection in human plasma: green approach using ZnO nanoparticles and graphene oxide. [PDF]

BMC Chem
Samy B, Mabrouk MM, Hamid MAA, Ahmed HM.
europepmc   +1 more source

Comparative Effect of SGLT2 Inhibitors and GLP-1 Agonists on Glycemic Control in Type 2 Diabetes Mellitus.

J Pharm Bioallied Sci
Prakash V, Gupta S, Singh S, Rawat A, Deshpande AV, Podder A, Jani P.   +6 more
europepmc   +1 more source